Lloyds Enterprises Limited Board Approves Unaudited Results and ₹500 Crore NCD Issuance for Q3 FY26
Lloyds Enterprises Limited announced the outcome of its Board Meeting held on February 9, 2026. The Board approved the Unaudited Financial…
Lloyds Enterprises Limited Board Approves Unaudited Financial Results and NCD Issuance up to ₹500 Cr
Lloyds Enterprises Limited announced the outcome of its Board Meeting held on February 9, 2026. The Board inter-alia approved the Unaudited…
Ceigall India Limited Board Approves CEO Appointment, Asset Divestment, and Q3 FY2025-26 Financial Results
Ceigall India Limited announced the outcome of its Board meeting held on February 09, 2026. Key decisions included the appointment of Mr. A.…
Electronics Mart India Limited Investor Presentation Highlights Q3 & 9M FY26 Performance
Electronics Mart India Limited (EMIL) released its Investor Presentation for the period ending December 31, 2025, covering Q3 and 9M FY26…
Sky Gold & Diamonds Limited Approves ESOP Grant, Vesting Modification, and Equity Allotment
The Nomination and Remuneration Committee (NRC) of Sky Gold & Diamonds Limited approved three key actions on February 9, 2026. Firstly, a…
Hindustan Unilever Limited Kwality Wall’s Announces Key Management Changes Under Scheme of Arrangement
Kwality Wall’s (India) Limited (KWIL), in connection with the Scheme of Arrangement with Hindustan Unilever Limited (HUL), has approved…
Electronics Mart India Limited Board Approves Unaudited Q3 FY26 Financial Results
Electronics Mart India Limited announced the outcome of its Board meeting held on February 9, 2026. The Board approved the Unaudited…
Godfrey Phillips India Responds to Query on Significant Trading Volume Increase
Godfrey Phillips India Limited issued a clarification on February 9, 2026, addressing a query from the BSE regarding an unusual surge in its…
Mankind Pharma Q3 FY’26 Results Conference Call Transcript Summary
Mankind Pharma reported a strong performance for Q3 FY’26, with overall revenue growing 11.5% YoY to INR3,567 crores, achieving an…
SPARC Board Approves Unaudited Q3 FY2026 Financial Results and Exceptional Item Related to New Labour Codes
Sun Pharma Advanced Research Company Limited (SPARC) announced the approval of its Unaudited Standalone and Consolidated Financial Results for…